Lupin Limited Cash Flow Conversion Efficiency
Lupin Limited cash flow conversion efficiency. Based on the latest financial reports, Lupin Limited (LUPIN) has a cash flow conversion efficiency ratio of 0.147x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Rs29.03 Billion ≈ $313.93 Million USD) by net assets (Rs197.28 Billion ≈ $2.13 Billion USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Cash Flow Conversion Efficiency of Lupin Limited (2004–2026)
Cash flow conversion efficiency of Lupin Limited from 2004 to 2026. This chart illustrates how Lupin Limited's cash flow conversion efficiency has evolved over time, based on yearly financial data. View today's stock price for Lupin Limited for real-time trading data and today's change.
Lupin Limited Cash Flow Conversion Ratio Explained
Lupin Limited cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.
Lupin Limited Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Lupin Limited ranked by their cash flow conversion efficiency. Also see Lupin Limited (LUPIN) total market value for the company's overall valuation and market capitalisation.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Moog Inc
NYSE:MOG-A
|
0.062x |
|
WISE PLC SPONS.ADR/1
F:6WS0
|
N/A |
|
Bentley Systems Inc
NASDAQ:BSY
|
0.158x |
|
Boston Properties Inc
NYSE:BXP
|
0.020x |
|
Littelfuse Inc
NASDAQ:LFUS
|
0.031x |
|
Topbuild Corp
NYSE:BLD
|
0.067x |
|
Maplebear Inc.
NASDAQ:CART
|
0.103x |
|
American Healthcare REIT, Inc.
NYSE:AHR
|
0.000x |
Annual Cash Flow Conversion Efficiency for Lupin Limited (2004–2026)
The table below shows the annual cash flow conversion efficiency of Lupin Limited from 2004 to 2026. Review LUPIN FCF generation index to assess how much free cash flow the company generates relative to operating cash flow.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2026-03-31 | Rs225.13 Billion ≈ $2.43 Billion |
Rs71.90 Billion ≈ $777.56 Million |
0.319x | +84.11% |
| 2025-03-31 | Rs172.94 Billion ≈ $1.87 Billion |
Rs30.00 Billion ≈ $324.43 Million |
0.173x | -31.66% |
| 2024-03-31 | Rs143.73 Billion ≈ $1.55 Billion |
Rs36.48 Billion ≈ $394.56 Million |
0.254x | +67.83% |
| 2023-03-31 | Rs125.43 Billion ≈ $1.36 Billion |
Rs18.97 Billion ≈ $205.15 Million |
0.151x | +403.24% |
| 2022-03-31 | Rs122.22 Billion ≈ $1.32 Billion |
Rs3.67 Billion ≈ $39.72 Million |
0.030x | -77.14% |
| 2021-03-31 | Rs138.58 Billion ≈ $1.50 Billion |
Rs18.22 Billion ≈ $197.02 Million |
0.131x | +12.60% |
| 2020-03-31 | Rs125.81 Billion ≈ $1.36 Billion |
Rs14.69 Billion ≈ $158.85 Million |
0.117x | -3.37% |
| 2019-03-31 | Rs137.89 Billion ≈ $1.49 Billion |
Rs16.66 Billion ≈ $180.17 Million |
0.121x | -6.05% |
| 2018-03-31 | Rs136.17 Billion ≈ $1.47 Billion |
Rs17.51 Billion ≈ $189.38 Million |
0.129x | -57.69% |
| 2017-03-31 | Rs135.32 Billion ≈ $1.46 Billion |
Rs41.14 Billion ≈ $444.86 Million |
0.304x | +1022.36% |
| 2016-03-31 | Rs111.95 Billion ≈ $1.21 Billion |
Rs-3.69 Billion ≈ $-39.90 Million |
-0.033x | -110.73% |
| 2015-03-31 | Rs88.98 Billion ≈ $962.30 Million |
Rs27.33 Billion ≈ $295.57 Million |
0.307x | +7.27% |
| 2014-03-31 | Rs69.99 Billion ≈ $756.86 Million |
Rs20.04 Billion ≈ $216.72 Million |
0.286x | +20.48% |
| 2013-03-31 | Rs52.64 Billion ≈ $569.24 Million |
Rs12.51 Billion ≈ $135.29 Million |
0.238x | +73.36% |
| 2012-03-31 | Rs40.85 Billion ≈ $441.80 Million |
Rs5.60 Billion ≈ $60.57 Million |
0.137x | -42.67% |
| 2011-03-31 | Rs33.33 Billion ≈ $360.41 Million |
Rs7.97 Billion ≈ $86.18 Million |
0.239x | -8.32% |
| 2010-03-31 | Rs25.93 Billion ≈ $280.46 Million |
Rs6.76 Billion ≈ $73.15 Million |
0.261x | -20.06% |
| 2009-03-31 | Rs14.39 Billion ≈ $155.63 Million |
Rs4.70 Billion ≈ $50.78 Million |
0.326x | +62.70% |
| 2008-03-31 | Rs12.89 Billion ≈ $139.41 Million |
Rs2.59 Billion ≈ $27.96 Million |
0.201x | -1.57% |
| 2007-03-31 | Rs8.73 Billion ≈ $94.45 Million |
Rs1.78 Billion ≈ $19.24 Million |
0.204x | -8.77% |
| 2006-03-31 | Rs5.89 Billion ≈ $63.68 Million |
Rs1.32 Billion ≈ $14.22 Million |
0.223x | +18.37% |
| 2005-03-31 | Rs4.91 Billion ≈ $53.05 Million |
Rs925.60 Million ≈ $10.01 Million |
0.189x | -79.18% |
| 2004-03-31 | Rs4.32 Billion ≈ $46.67 Million |
Rs3.91 Billion ≈ $42.29 Million |
0.906x | -- |
About Lupin Limited
Lupin Limited, together with its subsidiaries, operates as a pharmaceutical company in India, the United States, and internationally. The company operates in two segments: Pharmaceuticals and Others. It produces, develops, and markets various branded and generic formulations, biotechnology products, and active pharmaceutical ingredients (APIs). The company also offers products in the therapeutic … Read more